HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 12, 2013, Pages 4604-4609

  Xiong, Ying ^a   Zhao, Kai ^a   Wu, Jiaxi ^a,c   Xu, Zhiheng ^a   Jin, Shan ^b   Zhang, Yong Q ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b HUBEI UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Disease model; Genetic study

Indexed keywords

HISTONE DEACETYLASE 6; TAU PROTEIN; TUBULIN;

ACETYLATION; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DROSOPHILA; DRUG TARGETING; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FRAGMENTATION REACTION; GENE MUTATION; GENETIC SCREENING; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EPOTHILONES; HISTONE DEACETYLASES; HUMANS; MICE; MICE, KNOCKOUT; MICROTUBULES; MUSCLE CELLS; MUTATION; NEURONS; PACLITAXEL; PHOSPHORYLATION; TAU PROTEINS; TUBULIN MODULATORS;

EID: 84875241051     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1207586110     Document Type: Article

References (50)

1. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1159.
2. Iqbal K, et al. (1986) Defective brain microtubule assembly in Alzheimer's disease. Lancet 2(8504):421-426.
3. Bramblett GT, et al. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10(6):1089-1099.
4. Hong M, et al. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282(5395):1914-1917.
5. Cairns NJ, Lee VM, Trojanowski JQ (2004) The cytoskeleton in neurodegenerative diseases. J Pathol 204(4):438-449.
6. Ishihara T, et al. (2001) Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci 21(16):6026-6035.
7. Tanemura K, et al. (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 22(1):133-141.
8. Zhang B, et al. (2005) Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc Natl Acad Sci USA 102(1):227-231.
9. Brunden KR, et al. (2010) Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J Neurosci 30(41): 13861-13866.
10. Zhang B, et al. (2012) The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci 32(11):3601-3611.
11. Mudrakola HV, Zhang K, Cui B (2009) Optically resolving individual microtubules in live axons. Structure 17(11):1433-1441.
12. Jin S, et al. (2009) Drosophila tubulin-specific chaperone E functions at neuromuscular synapses and is required for microtubule network formation. Development 136(9): 1571-1581.
13. Yao A, et al. (2011) Drosophila FMRP regulates microtubule network formation and axonal transport of mitochondria. Hum Mol Genet 20(1):51-63.
14. Morris M, Maeda S, Vossel K, Mucke L (2011) The many faces of tau. Neuron 70(3): 410-426.
15. Kimura T, et al. (2010) Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss. J Biol Chem 285(49):38692-38699.
16. Du GP, et al. (2010) Drosophila histone deacetylase 6 protects dopaminergic neurons against alpha-synuclein toxicity by promoting inclusion formation. Mol Biol Cell 21(13):2128-2137.
17. Thies E, Mandelkow EM (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J Neurosci 27(11): 2896-2907.
18. Ruiz-Canada C, et al. (2004) New synaptic bouton formation is disrupted by misregulation of microtubule stability in aPKC mutants. Neuron 42(4):567-580.
19. Sherwood NT, Sun Q, Xue M, Zhang B, Zinn K (2004) Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function. PLoS Biol 2(12):e429.
20. Blard O, et al. (2007) Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. Hum Mol Genet 16(5):555-566.
21. Chee FC, et al. (2005) Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol Dis 20(3):918-928.
22. Hubbert C, et al. (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417(6887):455-458.
23. Matsuyama A, et al. (2002) In vivo destabilization of dynamic microtubules by HDAC6- mediated deacetylation. EMBO J 21(24):6820-6831.
24. Hempen B, Brion JP (1996) Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. J Neuropathol Exp Neurol 55(9):964-972.
25. Ding H, Dolan PJ, Johnson GV (2008) Histone deacetylase 6 interacts with the microtubule- associated protein tau. J Neurochem 106(5):2119-2130.
26. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL (2003) Domainselective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 100(8):4389-4394.
27. Kaluza D, et al. (2011) Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin. EMBO J 30(20):4142-4156.
28. Dompierre JP, et al. (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci 27(13):3571-3583.
29. Shulman JM, Feany MB (2003) Genetic modifiers of tauopathy in Drosophila. Genetics 165(3):1233-1242.
30. Nishimura I, Yang Y, Lu B (2004) PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116(5): 671-682.
31. Spittaels K, et al. (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 155(6): 2153-2165.
32. Stokin GB, et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307(5713):1282-1288.
33. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8(9):663-672.
34. Ishihara T, et al. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24(3): 751-762.
35. Cash AD, et al. (2003) Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol 162(5):1623-1627.
36. Yang XJ, Grégoire S (2005) Class II histone deacetylases: From sequence to function, regulation, and clinical implication. Mol Cell Biol 25(8):2873-2884.
37. Valenzuela-Fernández A, Cabrero JR, Serrador JM, Sánchez-Madrid F (2008) HDAC6: A key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol 18(6):291-297.
38. Kawaguchi Y, et al. (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115(6):727-738.
39. Lee JY, et al. (2010) HDAC6 controls autophagosome maturation essential for ubiquitin- selective quality-control autophagy. EMBO J 29(5):969-980.
40. Iwata A, Riley BE, Johnston JA, Kopito RR (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280(48): 40282-40292.
41. Olzmann JA, et al. (2007) Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol 178(6):1025-1038.
42. Pandey UB, et al. (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447(7146):859-863.
43. Kovacs JJ, et al. (2005) HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 18(5):601-607.
44. Cook C, et al. (2012) Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation. Hum Mol Gene 21(13):2936-2945.
45. Sudo H, Baas PW (2010) Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts. J Neurosci 30(21):7215-7226.
46. Mandelkow EM, Thies E, Trinczek B, Biernat J, Mandelkow E (2004) MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J Cell Biol 167(1): 99-110.
47. Reed NA, et al. (2006) Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 16(21):2166-2172.
48. Daire V, et al. (2009) Kinesin-1 regulates microtubule dynamics via a c-Jun N-terminal kinase-dependent mechanism. J Biol Chem 284(46):31992-32001.
49. Zhang Y, et al. (2008) Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol 28(5):1688-1701.
50. Butler KV, et al. (2010) Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc 132(31):10842-10846.